Titan Biotech Limited has approved a 1:4 bonus issue that will provide eligible shareholders with one fully paid ₹2 share for every four shares held. According to company filings, the board of directors has set Friday, October 23, 2026 as the record date to determine shareholder eligibility. The bonus shares will be allotted on Monday, October 26, 2026, with trading expected to commence on Tuesday, October 27, 2026. As per the BSE filing, the paid-up bonus equity shares will be available for trading on the next working date from the allotment date.
The specialty chemicals stock closed 1.57% higher at ₹406.90 per share on BSE on Friday, bringing the company's market capitalisation to ₹1,681.25 crore. The stock has delivered impressive returns across multiple timeframes, with a 91.44% return in 2026 so far. The specialty chemical stock, with a return on equity (ROE) of 22.35%, has demonstrated strong operational performance. The stock has also seen a 3.64% return over the week, indicating positive momentum ahead of the bonus issue.
The stock has demonstrated exceptional long-term performance with 57.72% growth in one year and 147% returns over two years. According to market data, the stock has delivered an impressive 453.30% return over three years, positioning it as a multibagger investment. This performance trajectory has contributed to the company's current market capitalisation of ₹1,681.25 crore. The corporate action follows the company's previous stock split, indicating a continued focus on shareholder value enhancement.
The bonus issue will result in the allotment of 1,03,29,625 fully paid-up bonus equity shares of ₹2 each in the proportion of 1:4. As per the BSE filing, the paid-up bonus equity shares will be available for trading on the next working date from the allotment date. This corporate action comes months after the firm executed a stock split, demonstrating the company's commitment to enhancing shareholder value. The bonus shares will be issued in the proportion of 1:4, meaning every eligible investor will receive one fully paid-up equity share for every four existing shares held.
